(Q46269995)

English

KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

1 reference

based on heuristic

inferred from title

1

object named as

John Marra

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

author name string

Justin Greene

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Jimmy Hwang

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Juan Du

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Lloyd Damon

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Tom Martin

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Jeffrey M Venstrom

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

language of work or name

0 references

publication date

25 March 2015

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Journal of Immunology

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

194

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

9

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

4222-4230

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Autologous stem cell transplantation for acute myeloid leukemia in first remission

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

HLA-identical sibling allogeneic peripheral blood stem cell transplantation with reduced intensity conditioning compared to autologous peripheral blood stem cell transplantation for elderly patients with de novo acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Acute myeloid leukemia, version 2.2013.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative conditioning.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Peripheral blood lymphocyte and monocyte recovery and survival in acute leukemia postmyeloablative allogeneic hematopoietic stem cell transplant

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Re-infused autologous graft natural killer cells correlates with absolute lymphocyte count recovery after autologous stem cell transplantation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Donor killer cell Ig-like receptor B haplotypes, recipient HLA-C1, and HLA-C mismatch enhance the clinical benefit of unrelated transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Mutational and Structural Analysis of KIR3DL1 Reveals a Lineage-Defining Allotypic Dimorphism That Impacts Both HLA and Peptide Sensitivity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

KIR and KIR ligand polymorphism: a new area for clinical applications?

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Licensing of natural killer cells by host major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

The strength of inhibitory input during education quantitatively tunes the functional responsiveness of individual natural killer cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

HLA alleles determine differences in human natural killer cell responsiveness and potency

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Breaking tolerance to self, circulating natural killer cells expressing inhibitory KIR for non-self HLA exhibit effector function after T cell-depleted allogeneic hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Innate or adaptive immunity? The example of natural killer cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

A novel duplex SSP-PCR typing method for KIR gene profiling

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

IPD--the Immuno Polymorphism Database.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

High-resolution HLA alleles and haplotypes in the United States population

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Endocytosis of major histocompatibility complex class I molecules is induced by the HIV–1 Nef protein

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Early lymphocyte recovery predicts superior survival after autologous stem cell transplantation in non-Hodgkin lymphoma: a prospective study

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

The protein made from a common allele of KIR3DL1 (3DL1*004) is poorly expressed at cell surfaces due to substitution at positions 86 in Ig domain 0 and 182 in Ig domain 1.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Killer cell immunoglobulin-like receptor 3DL1 licenses CD16-mediated effector functions of natural killer cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Cis association of Ly49A with MHC class I restricts natural killer cell inhibition

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Novel KIR3DL1 alleles and their expression levels on NK cells: convergent evolution of KIR3DL1 phenotype variation?

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Weak HLA and beta 2-microglobulin expression of neuronal cell lines can be modulated by interferon

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Associations between genes for killer immunoglobulin-like receptors and their ligands in patients with solid tumors.

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Autotransplantation versus HLA-matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Cytokine-induced memory-like natural killer cells

1 reference

https://api.crossref.org/works/10.4049%2FJIMMUNOL.1402124

21 January 2018

Identifiers

10.4049/JIMMUNOL.1402124

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/25810393

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46269995&oldid=2102585345"